Personal tools

MCL coexpression mm9:3259: Difference between revisions

From FANTOM5_SSTAR

Jump to: navigation, search
No edit summary
No edit summary
Line 6: Line 6:
|ontology_enrichment_disease=
|ontology_enrichment_disease=
|ontology_enrichment_uberon=UBERON:0002346!8.37e-20!64;UBERON:0003075!8.37e-20!64;UBERON:0007284!8.37e-20!64;UBERON:0000073!1.74e-18!54;UBERON:0001017!3.32e-18!73;UBERON:0001016!1.05e-17!75;UBERON:0010314!1.97e-17!92;UBERON:0001049!4.27e-17!52;UBERON:0005068!4.27e-17!52;UBERON:0006241!4.27e-17!52;UBERON:0007135!4.27e-17!52;UBERON:0003056!6.38e-17!49;UBERON:0004121!2.39e-16!95;UBERON:0000924!2.39e-16!95;UBERON:0006601!2.39e-16!95;UBERON:0010371!2.45e-16!73;UBERON:0000955!2.46e-15!47;UBERON:0006238!2.46e-15!47;UBERON:0002020!4.45e-15!34;UBERON:0002616!8.68e-15!46;UBERON:0003080!3.58e-14!40;UBERON:0002780!1.46e-13!39;UBERON:0001890!1.46e-13!39;UBERON:0006240!1.46e-13!39;UBERON:0003528!1.67e-13!29;UBERON:0002791!1.67e-13!29;UBERON:0001893!1.67e-13!29;UBERON:0000956!1.70e-09!21;UBERON:0001869!1.70e-09!21;UBERON:0000203!1.70e-09!21;UBERON:0002619!4.61e-08!17;UBERON:0002021!1.07e-07!10;UBERON:0000411!1.07e-07!10;UBERON:0001950!1.07e-07!10;UBERON:0000025!6.31e-07!114
|ontology_enrichment_uberon=UBERON:0002346!8.37e-20!64;UBERON:0003075!8.37e-20!64;UBERON:0007284!8.37e-20!64;UBERON:0000073!1.74e-18!54;UBERON:0001017!3.32e-18!73;UBERON:0001016!1.05e-17!75;UBERON:0010314!1.97e-17!92;UBERON:0001049!4.27e-17!52;UBERON:0005068!4.27e-17!52;UBERON:0006241!4.27e-17!52;UBERON:0007135!4.27e-17!52;UBERON:0003056!6.38e-17!49;UBERON:0004121!2.39e-16!95;UBERON:0000924!2.39e-16!95;UBERON:0006601!2.39e-16!95;UBERON:0010371!2.45e-16!73;UBERON:0000955!2.46e-15!47;UBERON:0006238!2.46e-15!47;UBERON:0002020!4.45e-15!34;UBERON:0002616!8.68e-15!46;UBERON:0003080!3.58e-14!40;UBERON:0002780!1.46e-13!39;UBERON:0001890!1.46e-13!39;UBERON:0006240!1.46e-13!39;UBERON:0003528!1.67e-13!29;UBERON:0002791!1.67e-13!29;UBERON:0001893!1.67e-13!29;UBERON:0000956!1.70e-09!21;UBERON:0001869!1.70e-09!21;UBERON:0000203!1.70e-09!21;UBERON:0002619!4.61e-08!17;UBERON:0002021!1.07e-07!10;UBERON:0000411!1.07e-07!10;UBERON:0001950!1.07e-07!10;UBERON:0000025!6.31e-07!114
|tfbs_overrepresentation_for_novel_motifs=0.752782,1.68931,0.722405,0.801166,0.587814,0.81763,0.919454,0.467321,0.479531,0.235304,0.870507,0.906098,0.467629,0.933025,0.608226,0,1.14208,0.578045,1.138,0.876292,0.679146,0.275782,0.932027,0.585919,0.731217,0.963352,0.437236,0.841386,1.55113,1.7585,0.825437,1.24901,0.575271,0.411696,0.608816,0.872889,0.563758,0.902078,0.536514,0.50014,0.582863,0.831295,0.261619,0.610669,0.474221,0.788421,1.05665,0.859154,0.235354,0.646474,1.12346,0.99279,0.971403,1.3966,1.41464,0.940919,0.657156,0.891887,1.08907,0.938668,1.22795,1.00308,0.494668,1.11142,0.953187,1.15459,1.55483,1.90983,1.22303,1.7608,0.700291,0.474956,4.92931,1.44925,0.416814,0.402065,0.411601,1.04436,1.20986,0.684144,1.19917,1.16055,1.00151,0.459035,1.32978,3.89074,0.568545,0.380977,1.06194,2.07346,1.62608,1.33496,1.26245,0.595071,3.3325,0.509215,0.464141,1.26539,1.05692,2.50519,0.563856,1.24872,1.37854,1.12409,1.12297,0.830796,1.18646,0.854628,2.77583,1.63106,0.744607,1.38039,0.685481,3.36152,1.63327,0.580657,1.79445,0.805461,1.14346,0.559153,1.45481,1.08896,0.965352,1.04338,1.68841,1.21376,0.928483,1.25534,1.55328,0.598722,1.36093,0.792832,1.52297,0.955954,1.65529,0.273451,0.762499,0.832891,1.60513,2.44352,2.04137,1.55966,0.978551,1.26,1.11604,0.831808,1.06002,2.40374,0.765221,0.589976,0.999018,1.32874,1.39822,0.516739,0.954936,1.48249,0.993889,0.622823,0.749933,0.762177,1.61484,1.32889,1.21423,0.741984,1.11251,0.94678,0.562367,0.904334,2.62466
}}
}}

Revision as of 22:38, 26 November 2012


Phase1 CAGE Peaks

 Short description
Mm9::chr1:193541872..193541909,+p2@Lpgat1
Mm9::chr1:193541914..193541940,+p3@Lpgat1
Mm9::chr1:193541949..193541969,+p4@Lpgat1


Enriched pathways on this co-expression cluster<b>Summary:</b><br>Canonical pathway gene sets were compiled from Reactome, Wikipathways and KEGG. For the major signaling pathways, the transcriptionally-regulated genes (downstream targets) were obtained from Netpath. Combined, the canonical pathways and downstream targets totaled 489 human gene sets. The corresponding M. musculus gene sets were inferred by homology using the HomoloGene database. Enrichment for each of the canonical 489 pathways and gene sets included in the co-expression cluster was assessed by the hypergeometric probability. The resulting P values were also then adjusted by the Benjamini-Hochberg method for multiple comparisons.<br><b>Analyst: </b>Emmanuel Dimont<br><br>link to source dataset<br>data


no results for this coexpression

Relative expression of the co-expression cluster over median <br>Analyst:





Enriched sample ontology terms on this co-expression cluster<b>Summary:</b>To summarize promoter activities (expression profile of a TSS region) across ~1000 samples, we performed enrichment analysis based on FANTOM5 Sample Ontology (FF ontology). The question here is “in which type of samples the promoter is more active”. To answer this question, we compared expressions (TPMs) in the samples associated with a sample ontology term and the rest of the samples by using the Mann-Whitney rank sum test. To summarize ontologies enriched in this co-expression cluster, we ran the same analysis on an averaged expression profile of all promoters that make up. <b>Analyst:</b> Hideya Kawaji <br><br>links to source dataset<br><br>cell_data<br>uberon_data<br><br>


Cell Type
Ontology termp-valuen
CNS neuron (sensu Vertebrata)1.23e-1023
neuroblast (sensu Vertebrata)1.23e-1023
neuron5.02e-1033
neuronal stem cell5.02e-1033
neuroblast5.02e-1033
electrically signaling cell5.02e-1033
electrically responsive cell1.15e-0839
electrically active cell1.15e-0839

Uber Anatomy
Ontology termp-valuen
neurectoderm8.37e-2064
neural plate8.37e-2064
presumptive neural plate8.37e-2064
regional part of nervous system1.74e-1854
central nervous system3.32e-1873
nervous system1.05e-1775
structure with developmental contribution from neural crest1.97e-1792
neural tube4.27e-1752
neural rod4.27e-1752
future spinal cord4.27e-1752
neural keel4.27e-1752
pre-chordal neural plate6.38e-1749
ectoderm-derived structure2.39e-1695
ectoderm2.39e-1695
presumptive ectoderm2.39e-1695
ecto-epithelium2.45e-1673
brain2.46e-1547
future brain2.46e-1547
gray matter4.45e-1534
regional part of brain8.68e-1546
anterior neural tube3.58e-1440
regional part of forebrain1.46e-1339
forebrain1.46e-1339
future forebrain1.46e-1339
brain grey matter1.67e-1329
regional part of telencephalon1.67e-1329
telencephalon1.67e-1329
cerebral cortex1.70e-0921
cerebral hemisphere1.70e-0921
pallium1.70e-0921
regional part of cerebral cortex4.61e-0817
occipital lobe1.07e-0710
visual cortex1.07e-0710
neocortex1.07e-0710
tube6.31e-07114


TFBS overrepresentation<b>Summary:</b>The values shown are the p-values for overrepresentation of the motif in this coexpression cluster. So a small p-value means a strong overrepresentation. <b>Analyst:</b> Michiel de Hoon <br><br>link to source data <br> Novel motifs <br>data <br><br> Jaspar motifs <br>data


Novel motifs




JASPAR motifs


Motifs-log10(p-value)

{{{tfbs_overrepresentation_jaspar}}}